Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Smith

Showing results (131-140 of 303) with videos related to

Pageof 31
Sort By:
Blood|January 17, 2004
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemiaB Douglas Smith, Mark Levis, Miloslav Beran, et al.
Stem Cells Translational Medicine|March 16, 2017
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex VivoKatherine L B Knorr, Laura E Finn, B Douglas Smith, et al.
Journal of Clinical Gastroenterology|January 15, 2009
HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirinWyel Hakim, Shehzad Sheikh, Irteza Inayat, et al.
JCO Oncology Practice|February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot StudyMirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Leukemia & Lymphoma|April 5, 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsTara M Robinson, Gabrielle T Prince, Chris Thoburn, et al.
Blood|November 25, 2003
Characterization of clonogenic multiple myeloma cellsWilliam Matsui, Carol Ann Huff, Qiuju Wang, et al.
Surgery|November 20, 2016
Parathyroidectomy prior to kidney transplant decreases graft failureGlenda G Callender, Jennifer Malinowski, Mahsa Javid, et al.
Leukemia Research|November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CMLJonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
Current Medical Research and Opinion|April 10, 2019
Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemiaJorge E Cortes, Bogdan Muresan, Carla Mamolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid LeukemiaJoshua F Zeidner, Daniel J Lee, Mark Frattini, et al.
Pageof 31

Showing results (131-140 of 303) with videos related to

Sort By:
Pageof 31
Blood|January 17, 2004
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemiaB Douglas Smith, Mark Levis, Miloslav Beran, et al.
Stem Cells Translational Medicine|March 16, 2017
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex VivoKatherine L B Knorr, Laura E Finn, B Douglas Smith, et al.
Journal of Clinical Gastroenterology|January 15, 2009
HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirinWyel Hakim, Shehzad Sheikh, Irteza Inayat, et al.
JCO Oncology Practice|February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot StudyMirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Leukemia & Lymphoma|April 5, 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsTara M Robinson, Gabrielle T Prince, Chris Thoburn, et al.
Blood|November 25, 2003
Characterization of clonogenic multiple myeloma cellsWilliam Matsui, Carol Ann Huff, Qiuju Wang, et al.
Surgery|November 20, 2016
Parathyroidectomy prior to kidney transplant decreases graft failureGlenda G Callender, Jennifer Malinowski, Mahsa Javid, et al.
Leukemia Research|November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CMLJonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
Current Medical Research and Opinion|April 10, 2019
Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemiaJorge E Cortes, Bogdan Muresan, Carla Mamolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid LeukemiaJoshua F Zeidner, Daniel J Lee, Mark Frattini, et al.
Pageof 31